Get the Stockscreener App
3.41
0.59%
0.02
Nutriband Inc stock is traded at $3.41, with a volume of 4,363.
It is up +0.59% in the last 24 hours and down -5.28% over the past month.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
See More
Previous Close:
$3.39
Open:
$3.36
24h Volume:
4,363
Relative Volume:
0.43
Market Cap:
$41.45M
Revenue:
$2.04M
Net Income/Loss:
$-8.23M
P/E Ratio:
-1.2876
EPS:
-2.6484
Net Cash Flow:
$-5.14M
1W Performance:
-3.40%
1M Performance:
-5.28%
6M Performance:
-29.55%
1Y Performance:
-52.31%
1-Day Range:
$3.29
$3.41
1-Week Range:
$3.29
$3.62
52-Week Range:
$3.209
$11.68
Nutriband Inc Stock (NTRB) Company Profile
Name
Nutriband Inc
Sector
Industry
Phone
407 377-6695
Address
121 S. ORANGE AVE., ORLANDO
Compare NTRB vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRB
Nutriband Inc
|
3.41 | 41.45M | 2.04M | -8.23M | -5.14M | -2.6484 |
VRTX
Vertex Pharmaceuticals Inc
|
450.46 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.98 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
884.20 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
287.80 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
160.06 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nutriband Inc Stock (NTRB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-25 | Initiated | Noble Capital Markets | Outperform |
Nutriband Inc Stock (NTRB) Latest News
NTRB Q1 2026 Earnings: Significant EPS Beat Amid Ongoing Pre-Revenue StageProfit Cycle Analysis - newsline.com
Nutriband Inc. Reports Q1 2026 Results: Revenue Down, Net Loss Narrows, and Continued Focus on Abuse Deterrent Technology – Minichart - Minichart
Nutriband Inc. Reports Earnings Results for the First Quarter Ended April 30, 2026 - marketscreener.com
[10-Q] NutriBand Inc. Quarterly Earnings Report - Stock Titan
Nutriband Inc. (NTRB) Slips Modestly as Stock Tests Key Support LevelsEarnings Quality Factor - newsline.com
Presidential hopeful Gareth Sheridan's Nutriband was fined by US government - MSN
Number of shareholders of Nutriband Inc. – NASDAQ:NTRBW - TradingView
Nutriband Inc. (NTRB) Holds Steady Near Support Level Amid ConsolidationAndrews Pitchfork - newsline.com
NTRB Q1 2026 Earnings: Narrowing Loss Significantly Exceeds ExpectationsCEO Earnings Statement - The Legal Advocate
Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.28 - Markets Mojo
Nutriband Inc.'s Equity Buyback announced on September 18, 2024, has expired. - marketscreener.com
NTRB Q1 2026 Earnings: EPS Beats Estimates by Wide Margin Despite Revenue AbsenceTech Earnings Analysis - newsline.com
Nutriband, Inc. Stock Plummets to New 52-Week Low of $3.38 - MarketsMojo
Nutriband (NTRB) Q1 2026 Earnings: Large EPS Beat on Minimal Loss vs. Deeply Negative Consensus - newsline.com
Nutriband (NTRB) Q1 2026 Earnings: Massive EPS Beat Drives Stock SurgeExpert Breakout Alerts - Newser
NTRBW | Nutriband Inc. Warrant Insider Trading - Quiver Quantitative
NTRB Q1 2026 Earnings: Massive EPS Beat Highlights Cost Control Amid Pre-Revenue StageStock Analysis Community - Newser
Nutriband Inc. (NTRB) Slides to Support as Traders Eye Key LevelsPrice Gap Fill - The Legal Advocate
Nutriband (NTRB) Stock: Down -1.45%, Support Test at $3.23 2026-05-20Low Vol Factor - thelegaladvocate.com
Nutriband Inc. 10-K/A Filing 2026 – Executive Compensation Clawback Policy, Certifications, and SEC Entity Information - Minichart
Nutriband (NTRB) files 10-K amendment to add executive compensation clawback policy - Stock Titan
Nutriband Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference - MEXC
Nutriband (NASDAQ: NTRB) Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference - Barchart.com
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference - The Manila Times
Active Intelligence and Nutriband Inc. Showcases Expanding Ai Wellness Product Portfolio and Announces New June Product Launches At Ecrm Conference - marketscreener.com
Nutriband (NTRBW) Stock Analysis: Range-Bound Near $$1.12 2026-05-14Institutional Flow Picks - The Legal Advocate
TradingKey - TradingKey
Nutriband (NTRB) Stock: Slides -2.78%, Support at $3.32 2026-05-13Rounding Bottom - The Legal Advocate
NTRB | Nutriband Inc. Common Stock Insider Trading - Quiver Quantitative
Nutriband (NTRB) Earnings Date and Reports 2026 $NTRB - MarketBeat
Nutriband Inc. Develops FDA-Targeted AVERSA™ Abuse Deterrent Transdermal Patch Technology for Opioid and Stimulant Drugs - Minichart
Nutriband Inc reports results for the quarter ended January 31Earnings Summary - TradingView
What naked margin Nutriband (NTRB)? (Risk Aversion) 2026-04-29Retail Flow - newser.com
[10-K] NutriBand Inc. Files Annual Report - Stock Titan
NutriBand 10-K: Revenue $2.04M, EPS (2.58) for year ended Jan 31, 2026 - TradingView
Nutriband Inc. Reports Earnings Results for the Full Year Ended January 31, 2026 - marketscreener.com
NTRB Nutriband posts far narrower Q1 2026 loss than analyst projections, shares edge higher on positive investor sentiment.Stock Trading Network - newser.com
Nutriband Inc expected to post a loss of $1.89 a shareEarnings Preview - TradingView
Nutriband (NASDAQ: NTRB) CEO Highlights AVERSA Technology on Jack Neel Podcast - Barchart.com
NTRBW Nutriband releases no quarterly earnings metrics, leaving investors awaiting clarity on near-term core business growth trajectory.Social Trading Insights - UBND thành phố Hải Phòng
Is Nutriband (NTRB) stock undervalued by investors | Q1 2026: Earnings Beat EstimatesInvestment Signal Network - Cổng thông tin điện tử tỉnh Lào Cai
NTRB (Nutriband Inc.) Q1 2026 results far outperform loss estimates, post mild revenue gains as shares rise modestly.High Volatility - UBND thành phố Hải Phòng
NTRB Nutriband Q1 2026 earnings beat estimates by wide margin, shares post modest daily gains.AI Stock Signals - Cổng thông tin điện tử tỉnh Lào Cai
Nutriband CEO Discusses AVERSA Technology's Role in Addressing Opioid Crisis on Podcast - citybuzz -
Nutriband Inc Stock (NTRB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):